Azenta, Inc. (AZTA)

Nasdaq Health Care Life Sciences Tools & Services S&P SmallCap 600
$39.16
+1.78 (+4.76%)
Close of Nov 06, 2026 · end-of-day data
Source: Azenta, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$434.01M$527.50M$631.56M$334.18M$388.54M$513.70M$555.50M$551.49M$573.45M$593.82M
Cost of revenue$362.24M$425.48M$385.48M$199.57M$216.39M$269.89M$299.91M$312.28M$318.83M$323.54M
Gross profit$156.69M$198.89M$246.08M$134.60M$172.15M$243.81M$255.58M$239.21M$254.62M$270.28M
Research & development$44.24M$39.88M$46.94M$17.32M$17.82M$22.41M$27.54M$32.14M$31.52M$30.39M
Selling, general & admin$119.29M$141.55M$167.02M$163.33M$190.26M$252.10M$251.47M$263.74M$262.96M$261.56M
Operating income-$17.05M$14.32M$31.41M-$47.43M-$36.60M-$31.09M-$24.73M-$61.25M-$51.28M-$26.84M
Interest expense$157.00K$408.00K$9.52M$22.25M$2.94M$2.04M$4.59M———
Pre-tax income-$18.14M$14.52M$20.47M-$83.96M-$40.29M-$48.97M-$9.94M-$20.00M-$19.12M-$7.14M
Income tax$66.25M$3.38M-$47.25M-$22.83M-$13.93M-$20.10M$1.35M-$11.96M$5.24M-$31.60M
Net income-$69.48M$62.61M$116.58M$437.42M$64.85M$110.75M$2.13B-$14.64M-$164.90M-$55.76M
EBITDA$10.99M$42.47M$68.84M$7.02M$28.90M$34.24M$28.97M$24.34M$39.46M$34.37M
EPS (basic)$-1.01$0.90$1.65$6.08$0.88$1.49$28.48$-0.22$-3.10$-1.22
EPS (diluted)$-1.01$0.89$1.64$6.04$0.88$1.49$28.48$-0.22$-3.10$-1.22
Diluted shares68.51M70.48M70.94M72.39M73.85M74.45M74.90M66.25M53.17M45.90M
Gross margin36.1%37.7%39.0%40.3%44.3%47.5%46.0%43.4%44.4%45.5%
Operating margin-3.9%2.7%5.0%-14.2%-9.4%-6.1%-4.5%-11.1%-8.9%-4.5%
Net margin-16.0%11.9%18.5%130.9%16.7%21.6%384.0%-2.7%-28.8%-9.4%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$85.09M$101.62M$197.71M$256.64M$250.65M$227.43M$658.27M$649.48M$280.03M$279.78M
Short-term investments——$46.28M$34.12M$51.00K$81.00K$911.76M$338.87M$151.16M$61.14M
Receivables$106.37M$93.47M$125.19M$165.60M$94.79M$119.88M$163.76M$156.53M$154.17M$142.18M
Inventory$92.57M$73.40M$96.99M$99.44M$37.12M$60.40M$85.54M$128.20M$71.32M$74.96M
Total current assets$299.33M$351.78M$564.06M$647.14M$649.45M$777.37M$2.46B$1.42B$833.03M$708.34M
Goodwill$175.65M$207.15M$255.88M$440.75M$453.18M$469.36M$513.62M$675.36M$691.41M$702.39M
Total assets$685.90M$766.63M$1.10B$1.52B$1.56B$1.82B$3.72B$2.89B$2.10B$2.06B
Total current liabilities$119.79M$146.78M$164.62M$272.27M$211.12M$345.09M$230.55M$210.93M$206.09M$237.67M
Short-term debt——$2.00M$829.00K$827.00K—————
Long-term debt——$194.07M$50.31M$49.59M$49.68M————
Total debt——$196.07M$51.14M$50.41M$49.68M————
Total liabilities$132.22M$158.98M$377.43M$377.05M$345.65M$494.18M$352.74M$351.22M$332.42M$332.60M
Shareholders' equity$553.69M$607.64M$717.83M$1.14B$1.21B$1.33B$3.36B$2.53B$1.77B$1.73B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$39.55M$96.22M$73.96M$90.90M$37.87M$149.86M-$466.05M$5.83M$49.74M$72.18M
Capital expenditures$12.85M$12.68M$12.79M$23.86M$39.92M$52.80M$73.44M$39.44M$37.39M$33.86M
Free cash flow$26.70M$83.55M$61.18M$67.04M-$2.06M$97.05M-$539.48M-$33.60M$12.35M$38.32M
Investing cash flow-$10.87M-$54.19M-$148.47M$211.31M-$22.74M-$146.35M$1.47B$431.38M$224.74M-$90.46M
Financing cash flow-$25.96M-$25.92M$170.28M-$191.16M-$27.02M-$25.91M-$62.76M-$840.46M-$659.21M-$9.59M
Dividends paid$27.50M$27.93M$28.29M$28.89M$29.51M$29.73M$7.49M$0$0—
Share buybacks——————$0$838.51M$661.70M$0
Stock-based compensation$11.74M$17.28M$19.82M$20.11M$16.32M$27.46M$10.67M$9.38M$14.47M$20.88M
Depreciation & amortization$28.05M$28.15M$37.43M$54.45M$65.50M$65.33M$53.70M$85.58M$90.74M$61.21M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.